Key points are not available for this paper at this time.
Although CDK inhibitors may stem the proliferation of cancer cells, resistance remains an issue, and currently there are limited biomarkers to predict response to therapy. Ongoing research investigating CDK inhibitors in cancer is of paramount importance to define appropriate and effective treatment regimens.
Building similarity graph...
Analyzing shared references across papers
Loading...
Komal Jhaveri
Brooklyn Hospital Center
Howard A Burris rd
Sarah Cannon
Timothy A. Yap
The University of Texas MD Anderson Cancer Center
Expert Review of Anticancer Therapy
Cornell University
University of California, Los Angeles
University of California, San Francisco
Building similarity graph...
Analyzing shared references across papers
Loading...
Jhaveri et al. (Mon,) studied this question.
synapsesocial.com/papers/6a185c7e36f65e9da61eb991 — DOI: https://doi.org/10.1080/14737140.2021.1944109